Viewing Study NCT03208712


Ignite Creation Date: 2025-12-26 @ 10:17 PM
Ignite Modification Date: 2025-12-31 @ 8:02 PM
Study NCT ID: NCT03208712
Status: TERMINATED
Last Update Posted: 2018-10-24
First Post: 2017-07-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based Chemotherapy
Sponsor: University of Michigan Rogel Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module